M4MM
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
Jushi Holdings Reports Q3 2025 Financial Results
LOS ANGELES – Jushi Holdings Inc., a vertically integrated Cannabis operator with footprints in six states, disclosed third-quarter 2025 financials that showed revenue climbing 6.6% year-over-year to $65.7 million, driven by higher wholesales and customer ...
Compass Pathways Advances Psilocybin Therapy Timeline for Depression Treatment
LONDON & NEW YORK – Compass Pathways reported Q3 2025 financial results and signaled a faster path to market for its lead psilocybin-based therapy in treatment-resistant depression (TRD). The biotechnology firm now targets commercialization readiness ...
Missouri Trade Group Report Finds 96% of Tested Hemp Products Exceed THC Thresholds
KANSAS CITY – A new investigation by the Missouri Cannabis Trade Association (MoCannTrade) has concluded that nearly all hemp-derived products sold at unregulated retailers in the state contain illegal levels of THC, raising questions about ...
New Mexico Cannabis Market Edges Toward $2B in Total Sales
ALBUQUERQUE – New Mexico's Cannabis industry has recorded $1.9 billion in combined medical and adult-use sales since recreational legalization took effect in April 2022, according to the latest figures from the state’s Regulation and Licensing ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
Ascend Wellness Secures $50 Million Through Private Placement of Senior Secured Notes
LOS ANGELES- Ascend Wellness Holdings, Inc. a multi-state, vertically integrated cannabis operator, has completed a $50 million private placement of its 12.75% senior secured notes due 2029. The notes, issued at 97.5% of face value, ...
Alphabet Soup: Common Acronyms in Cannabis and Why You Need to Know Them
LOS ANGELES- Running a cannabis business means speaking more than the language of cultivation and branding — it means speaking compliance, with all its acronyms. You’ve likely seen a wall of them — ADA, OSHA, ...
Financial and Regulatory Hurdles Challenge New Cannabis Enterprises
LOS ANGELES- Emerging cannabis businesses in the United States are encountering significant barriers to entry, primarily due to financial constraints, complex regulatory environments, and competition from established entities. Access to capital remains a primary obstacle ...
Cannabis Use Among Seniors Sees Significant Uptick
LOS ANGELES- A recent study published in JAMA Internal Medicine highlights a notable increase in cannabis use among U.S. adults aged 65 and older. Data from the National Survey on Drug Use and Health indicates ...
FLUENT Corp. Expands Indoor Cultivation with Rosa Facility in Florida
LOS ANGELES- FLUENT Corp.a vertically integrated cannabis operator, has initiated cultivation at its new Rosa indoor facility in Tampa, Florida. This development adds 9,200 square feet of high-efficiency indoor canopy to the company's operations, marking ...
Atai Life Sciences and Beckley Psytech Announce Strategic Merger to Form Atai Beckley
LOS ANGELES- Atai Life Sciences, a biopharmaceutical company, and Beckley Psytech, a private UK-based biotechnology firm, have announced a definitive agreement to merge, creating a new entity named Atai Beckley. The all-share transaction values Beckley ...
Comprehensive Cannabis Pangenome
LOS ANGELES- A collaborative study led by the Salk Institute for Biological Studies has constructed the most comprehensive genetic map of Cannabis sativa to date, analyzing 193 genomes from 144 biological samples. This pangenome reveals ...
Cresco Labs Reports $30 Million in Q1 Operating Cash Flow
LOS ANGELES- Cresco Labs Inc. reported $30 million in operating cash flow for the first quarter of 2025, reflecting its ongoing emphasis on cash generation and financial discipline. This figure follows a record $132 million ...
California Cannabis Industry Pursues Self-Regulation
LOS ANGELES- In response to ongoing regulatory challenges and concerns about product safety, California's cannabis industry is exploring self-regulation measures to bolster consumer trust and ensure compliance within the legal market. The Environmental Consumer Compliance ...
AYR Wellness Delays Q1 2025 Financial Filings Amid Strategic Review
LOS ANGELES- AYR Wellness Inc., a U.S.-based multi-state cannabis operator, announced a delay in filing its Q1 2025 financial statements and Management’s Discussion and Analysis (MD&A), originally due on May 30, 2025. The company cited ...
Australia’s Legal Cannabis Market Projects Significant Growth
LOS ANGELES- Australia's legal cannabis market is poised for substantial expansion, with projections estimating growth from USD 126.32 million in 2024 to USD 420.33 million by 2030, reflecting a compound annual growth rate (CAGR) of ...
Texas Expands Medical Cannabis Access
LOS ANGELES- In a significant policy shift, Texas lawmakers have approved House Bill 46, expanding the state's medical cannabis program to include patients with chronic pain and those in hospice or terminal care. The bill ...
Cresco Labs Reschedules Q1 2025 Earnings
LOS ANGELES- Cresco Labs Inc. has announced an updated schedule for its first quarter 2025 financial disclosures. The company will file its interim financial statements and Management’s Discussion and Analysis (MD&A) on Friday, May 30, ...
London Mayor Advocates for Decriminalization of Cannabis Possession
LOS ANGELES- London Mayor Sadiq Khan has endorsed recommendations from the London Drugs Commission (LDC) to decriminalize the possession of small quantities of natural cannabis for personal use. The LDC, established by Khan in 2022 ...
New Zealand Medicinal Cannabis Firms Propose Merger to Form Helius Health
LOS ANGELES- Three of New Zealand's medicinal cannabis companies—Helius Therapeutics, Green Leaf Group, and Elysian Group—have announced plans to merge into a single entity named Helius Health. The proposed consolidation aims to integrate the full ...
